Description
Endogenous Copper Tripeptide Research Compound
GHK-Cu (50mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.
GHK-Cu is a naturally occurring copper tripeptide whose endogenous concentration declines with age — from approximately 200 ng/mL in plasma at age 20 to ~80 ng/mL at 60. This decline is studied in the context of reduced skin thickness, elasticity, and tissue repair capacity. GHK-Cu has one of the broadest activity profiles in the dermal-research literature: collagen synthesis, wound healing, inflammatory signalling, and gene-expression modulation in ageing tissue.
It is the same compound used in cosmetic serums at low topical concentrations. Research-grade lyophilized peptide is supplied for protocols requiring controlled, higher-concentration study.
Key Research Areas
- Collagen & Elastin Synthesis — Studied for stimulating structural protein production in dermal fibroblasts
- Wound Healing — Studied across multiple wound healing models for accelerated epidermal repair
- Dermal Gene Expression — Studied for influence on >4,000 human genes, including repair, renewal, and inflammation pathways
- Inflammation Modulation — Studied for reducing chronic low-grade dermal inflammation
Supplied as lyophilized powder at ≥98% purity, verified by HPLC and mass spectrometry. 50mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.